Trastuzumab in HER2-positive Biliary Tract Cancer

Clinical trial NCT03613168 · COMPLETED

Trial details

NCT number: NCT03613168
Sponsor: Changhoon Yoo
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma Biliary Tract Cancer HER-2 Protein Overexpression HER-2 Gene Amplification

Start date: 2019-06-01
Primary completion: 2020-11-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.